Riskpilot← Back to searchSign inGet full accessENEBAKK BIOPRODUKTER AS
ASActiveOrg 927403188Sørfjordveien 568, 7113 HusbysjøenFreight transport by road · NACE 4941Est. 20210 employees
Revenue 2025
NOK 2M
+32% vs 2024
EBITDA margin
18.2%
+162% vs 2024
Equity ratio
37.5%
Financial strength
Net profit 2025
NOK 252K
+2157% vs 2024
| Revenue | NOK 2M | +32% |
| EBITDA | NOK 364K | +162% |
| Net profit | NOK 252K | +2157% |
| Total assets | NOK 1,2M | +43% |
| Equity | NOK 443K | +132% |
| Employees | 0 | — |
Legal name
ENEBAKK BIOPRODUKTER AS
Org number
927403188
Legal form
Aksjeselskap
NACE code
4941 · Freight transport by road
Founded
9. juli 2021
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Innsamling av bygningsavfall, avfallshåndtering og levering til gjenbruk og andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Sørfjordveien 568, 7113 Husbysjøen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 411 | 1 614 | 1 782 | 1 514 | 2 001 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −118 | 207 | 191 | 139 | 364 |
| Depreciation & amort. | −55 | −57 | −57 | −82 | −26 |
| EBIT | −173 | 150 | 134 | 57 | 338 |
| Net financials | 0 | −60 | −97 | −35 | −22 |
| Profit before tax | −173 | 90 | 37 | 22 | 316 |
| Tax | −0 | 6 | 0 | 11 | 63 |
| Net profit | −173 | 84 | 36 | 11 | 252 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 848 | 1 204 | 1 031 | 827 | 1 181 |
| Equity | 60 | 143 | 180 | 191 | 443 |
| Long-term debt | 99 | 922 | 591 | 110 | 0 |
| Short-term debt | 689 | 139 | 261 | 526 | 622 |
| Total debt | 789 | 1 061 | 851 | 636 | 737 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20212025
Equity ratio
37.5%
This company
38.2%
Market median
+2% vs market
20212025
Return on equity
56.9%
This company
18.4%
Market median
+209% vs market
20212025
Net profit margin
12.6%
This company
8.1%
Market median
+56% vs market
20212025
Asset turnover
1.69×
This company
1.12×
Market median
+51% vs market
20212025
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-05-31 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENEBAKK BIOPRODUKTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marvin Enebakk | Board of Directors | 0 companies |
| Kai Enebakk | Board of Directors | 0 companies |
| Mads Enebakk | Chairman | 0 companies |
| Magne Hilmar Enebakk | Chairman | 0 companies |